P&G Braces For “Tough Year” Of Navigating Turbulent Economy
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble is bracing for increased commodity costs, weak exchange rates and price increases even though a "balanced brand and geographic portfolio" have insulated it from the global economic downturn so far, the company says
You may also be interested in...
FDA Denies P&G Petition For OTC Proton Pump Inhibitor Class Labeling
FDA's rejection of a Procter & Gamble citizen petition seeking class labeling for OTC proton pump inhibitors clears a roadblock for Schering-Plough's Zegerid to potentially make an "immediate release" claim
FDA Denies P&G Petition For OTC Proton Pump Inhibitor Class Labeling
FDA's rejection of a Procter & Gamble citizen petition seeking class labeling for OTC proton pump inhibitors clears a roadblock for Schering-Plough's Zegerid to potentially make an "immediate release" claim
FDA Denies P&G Petition For OTC Proton Pump Inhibitor Class Labeling
FDA's rejection of a Procter & Gamble citizen petition seeking class labeling for OTC proton pump inhibitors clears a roadblock for Schering-Plough's Zegerid to potentially make an "immediate release" claim